Among AI’s most watchful stakeholders are healthcare organizations in need of AI talent and AI talent in need of work in healthcare. Both groups need to keep up with the technology in its present as well as future iterations.

Meet a recent high-school graduate who’s built a brilliant AI app. 

Some 60% of IT professionals and 51% of operational leaders admit they’re reluctant to involve clinicians in software decisions. 

The FDA clearly sees significant potential in this new screening software from New York-based AccurKardia.

Public interest is piqued over AI-aided cancer detection. 

As 2024 winds down and the number of FDA-approved medical devices packing AI approaches 1,000—the agency had the tally at 950 as of August—the industry finds itself at a “critical inflection point.” 

Deep fakes are more dangerous to healthcare than we may have thought. 

Nurses tend to feel optimistic if not exactly excited about AI’s advances into their profession. Those who hold back tend to share a common concern—sacrificing care quality for the sake of tech-enabled efficiency. 

AI didn’t displace the nearly 3,000 people who just lost their jobs at CVS. 

Generative AI is fixing to transform the pharmaceutical industry. However, not all adopters will reap rewards in comparable degrees.